Organised by SHC

The Science of HBV Cure Meeting 2026 LIVE

For Scientists, Clinician Scientists and
Pharmacists and Industry Experts

4 – 5 September 2026

9.00am – 5.30pm (SGT)

The Science of HBV Cure Meeting 2026 LIVE

4 – 5 September 2026

9.00am – 5.30pm (SGT)

Who Should Attend?

The Science of HBV Cure Meeting is important for patients, doctors, scientists and pharmaceutical companies seeking to understand Hepatitis B and its new treatments. In particular, Hepatitis B cure is becoming a reality with new drugs tested in phase 3 clinical trials.

Additionally, HDV is also emerging as an important disease for which therapy is rapidly evolving.

At the 2nd Asian Hepatology Summit, you may choose to:

(1) Register for SHC 2026 ONLINE only: and be able to attend the SHC 2026 conference online and have access to the slides and videos recorded of the conference (subject to speaker consent).
Or

(2) Register for the HBV Cure Meeting 2026 LIVE: and be able to attend HBV Cure Meeting 2026 LIVE and attend SHC 2026 ONLINE (Note HBV Cure Meeting is not offered online) and have access to the slides and videos recorded of the conference (subject to speaker consent).

To access e-Resources REGISTER HERE or LOG IN (if you have previously registered for SHC or AHS)

Meet Our Experts

Coming Soon..

The Science of HBV Cure Meeting 2026 LIVE Scientific Programme
Full Programme currently in preparation

Call for Abstracts

Submission Deadline: 7 July 2025

We invite all interested parties to present their research papers. (abstracts of Case Studies will not be accepted) Click on below Abstracts and Posters for further information.

Abstracts will be reviewed by the Abstract Selection Committee and accepted submissions will be posted on Abstract & Poster Gallery in our website and in the Poster Hall. Presenters of oral presentations of accepted Abstracts as Free Papers will be receive a payment of USD800 to help defray the cost of travel and accommodation here in Singapore and a registration fee refund after the presentation.

Only abstracts of research papers will be accepted. Abstracts of Case Studies will not be accepted.